Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy (Q35623628)
Jump to navigation
Jump to search
scientific article published on 17 September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy |
scientific article published on 17 September 2012 |
Statements
1 reference
Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy (English)
1 reference
A Hallqvist
C Andersson
H Sjögren
A Hussein
17 September 2012
1 reference
17 September 2012
1 reference